Daiichi Sankyo mRNA COVID vaccine meets main goal in trial as booster shot

Retrieved on: 2022-11-15 10:35:53

Tags for this article:

Click the tags to see associated articles and topics

Daiichi Sankyo mRNA COVID vaccine meets main goal in trial as booster shot. View article details on hiswai:

Excerpt

Daiichi Sankyo (DSKYF) (DSNKY) said its mRNA-based COVID-19 vaccine DS-5670 met the main goal in a booster vaccination trial.

Article found on: seekingalpha.com